Immediate Impact
1 from Science/Nature 71 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Works of Hidefumi Wada being referenced
Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041)
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Hidefumi Wada | 183 | 186 | 129 | 19 | 333 | |
| Olga Vornicova | 224 | 103 | 172 | 23 | 359 | |
| George Blumenschein | 213 | 49 | 77 | 20 | 333 | |
| Megan D. Schollenberger | 272 | 43 | 106 | 15 | 369 | |
| Elisabetta Broseghini | 125 | 69 | 87 | 22 | 366 | |
| Howard R. Gray | 100 | 218 | 126 | 14 | 304 | |
| Valeria Coco | 152 | 144 | 179 | 16 | 324 | |
| C. Guillén-Barona | 110 | 158 | 145 | 26 | 295 | |
| Tina Petrogiannis‐Haliotis | 155 | 69 | 58 | 17 | 311 | |
| Sudip Thakar | 179 | 57 | 115 | 14 | 293 | |
| S. Lischner | 140 | 133 | 141 | 24 | 347 |
All Works
Loading papers...